Nu Skin Enterprises, Inc. (NUS)
| Previous close | 12.41 |
| Open | 12.47 |
| Bid | 12.39 x 900 |
| Ask | 12.42 x 800 |
| Day's range | 12.37 - 12.64 |
| 52-week range | 11.73 - 39.12 |
| Volume | |
| Avg. volume | 796,440 |
| Market cap | 614.349M |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | 72.76 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.24 (1.93%) |
| Ex-dividend date | 23 Feb 2024 |
| 1y target est | N/A |
- Business Wire
Nu Skin Enterprises to Announce First Quarter 2024 Financial Results
PROVO, Utah, April 03, 2024--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2024 results after the market closes on Wednesday, May 8. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives.
- PR Newswire
Nu Skin Launches RenuSpa iO, a New Personalized Beauty and Wellness Device
Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today introduced Nu Skin RenuSpa iO, a smart beauty and wellness device designed to promote overall wellness and body confidence through skin stimulation. RenuSpa iO is an FDA-cleared microcurrent body device and the latest innovation from the world's best-selling brand for beauty device systems for six consecutive years.*
- Business Wire
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2023 Results Above Company Guidance
PROVO, Utah, February 14, 2024--Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2023 results slightly above its latest guidance.
